Anavex Encouraged by New Scientific Data Revealing Positive Role of Sigma-1 Receptors in Brain Injuries April 7, 2015
Anavex Presents Positive Results for Both ANAVEX 2-73 and ANAVEX 3-71 in Alzheimer’s Models at 2015 AD/PD™ Conference March 23, 2015
Anavex Appoints Epilepsy and Clinical Trial Methodology Expert to Scientific Advisory Board March 12, 2015
Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries March 11, 2015
Anavex Appoints Scientific Advisory Board Member with Expertise in Protein Misfolding Neurodegenerative Diseases March 5, 2015
ANAVEX 2-73 Could Prevent Alzheimer’s Disease in Addition to Modifying and Treating Symptoms February 25, 2015
Amarantus Announces First Alzheimer’s Biomarker Services Collaboration for LymPro Test® with Anavex Life Sciences Corp. February 18, 2015
